BioCardia BCDA
NASDAQ BCDA
$0.92 -0.01 (-1.08%)
At close: Oct 23, 2026 · 4:00 PM EDT

BioCardia (BCDA) Gains from Investment Securities (2019)

Updated

Analysis

BioCardia (BCDA) Gains from Investment Securities (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 BioCardia 11.13 Mn -1.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 52,000.00
API Access

BioCardia Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=BCDA&period=max&api_key=YOUR_API_KEY